文献速递消化道肿瘤与早癌消化内镜

COVID-19疫情期间粪便检测、结肠镜检查利用及结直肠肿瘤检出率的反弹

Rebound in Fecal Testing, Colonoscopy Utilization, and Colorectal Neoplasia Detection During the COVID-19 Pandemic.
PubMed 文献 · Am J Gastroenterol · 2025-01-06

该回顾性队列研究评估了Kaiser Permanente北加州医疗系统50-75岁筛查合格患者在2019-2021年的结直肠癌检测利用和肿瘤检出情况。与2019年相比,2020年粪便免疫化学检测(FIT)、结肠镜检查、FIT阳性率和肿瘤检出率均下降,2021年出现强劲反弹,按年龄、性别、种族和民族或语言偏好划分的少数族裔亚组在2021年恢复中未见明显滞后。

要点

  • 2020年FIT、结肠镜检查、FIT阳性率和肿瘤检出率较2019年下降,2021年强劲反弹。
  • 按年龄、性别、种族和民族或语言偏好划分的少数族裔亚组在2021年恢复中未见明显滞后。
  • 白人和英语偏好者在恢复至基线水平方面存在小幅滞后。

核心结论

  • 2020年结直肠癌检测和肿瘤检出下降后,2021年出现强劲反弹,少数族裔亚组未见明显恢复滞后。
  • 研究结果可能有助于指导机构改善结直肠癌筛查并减少与国家紧急事件相关的医疗差异。
  • 需要长期研究评估疫情相关筛查实践变化对未来结直肠癌结局的影响。

研究设计与样本

  • 采用回顾性队列研究设计,纳入Kaiser Permanente北加州医疗系统2019-2021年50-75岁筛查合格患者。
  • 逐年评估FIT和结肠镜检查利用、FIT阳性率及肿瘤检出率,总体及按性别、年龄、种族和民族、语言偏好分层。

主要发现

  • 与2019年相比,2020年FIT、结肠镜检查、FIT阳性率和肿瘤检出率下降,2021年出现强劲反弹。
  • 按年龄和性别或按种族和民族、语言偏好划分的少数族裔亚组在2021年恢复中未见明显滞后。
  • 白人和英语偏好者在恢复至基线水平方面存在小幅滞后。
  • 2020年结肠镜检查检测下降被FIT利用较小幅度下降所抵消,2021年FIT利用强劲反弹有助于抵消2021年完成结肠镜检查反弹的小幅滞后。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要长期研究评估疫情相关结直肠癌筛查实践变化对未来结直肠癌结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The COVID-19 pandemic reduced colorectal cancer (CRC) screening, but the rebound in testing and outcomes after the pandemic has not been widely reported. We evaluated CRC test utilization and colorectal neoplasia detection among screening eligible patients in a large health system in 2020 and 2021, compared with 2019 (prepandemic). METHODS: Using a retrospective cohort study design, fecal immunochemical test (FIT) and colonoscopy utilization, FIT positivity, and neoplasia detection were evaluated annually in 2019-2021 among Kaiser Permanente Northern California patients aged 50-75 years overall and by sex, age, race and ethnicity, and spoken language preference. RESULTS: Compared with 2019, reductions in FIT, colonoscopy, FIT positivity, and neoplasia detection in 2020 were followed by a strong rebound in 2021 and no subgroups by age and sex or minority subgroups by race and ethnicity or spoken language preference demonstrably lagged in their recovery in 2021. Among White persons and those with an English language preference, there was a small lag in recovery to baseline levels. The overall decline in CRC testing by colonoscopy in 2020 was offset by a lesser decrease in FIT utilization in 2020, and a strong rebound in FIT utilization in 2021 helped to offset the small lag in the rebound in colonoscopies completed in 2021. DISCUSSION: Findings may help guide organizations looking to improve CRC screening and minimize health care disparities related to national emergencies such as pandemics. Long-term studies are needed to evaluate how pandemic-related changes in CRC screening practices will affect future CRC outcomes.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Langevin MJ, Jensen CD, Marks AR, et al. Rebound in Fecal Testing, Colonoscopy Utilization, and Colorectal Neoplasia Detection During the COVID-19 Pandemic. Am J Gastroenterol. 2025. PMID: 39760381. doi:10.14309/ajg.0000000000003293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。